J Korean Med Assoc.  2016 Aug;59(8):622-628. 10.5124/jkma.2016.59.8.622.

Prevention and treatment of healthcare-associated infections

• Chang MS
• Woo JH

• KMID: 2349839
• DOI: http://doi.org/10.5124/jkma.2016.59.8.622

Abstract

Healthcare-associated infections are infections that develop within a hospital and were not present or incubating upon admission. Almost all healthcare-associated infections become evident 2 days after admission. A patient may develop a healthcare-associated infection after hospital discharge if the pathogen was acquired in the hospital. Healthcare-associated infections most frequently involve the urinary tract, surgical sites, the lower respiratory tract, and the bloodstream, with Escherichia coli and Staphylococcus aureus being the most common pathogens identified. The microorganisms of healthcare-associated infections are usually more antimicrobial resistant than the same ones of community origin. Prevention of healthcare-associated infections, as well as those related to intravenous devices, requires standard infection control procedures: in other words, universal precautions including hand hygiene by all healthcare workers. Management of healthcare-associated infections includes supportive care, underlying disease treatment, displacement of an intravenous or intraurethral device and appropriate antimicrobial therapy. Healthcare-associated infections are not only a personal health issue but also a public health issue; therefore, the public and the government should cooperate to contribute to developing and implementing rational solutions for these infections.

Keyword

Cross infection; Prevention & control; Therapeutics

MeSH Terms

Cross Infection
Delivery of Health Care
Escherichia coli
Hand Hygiene
Humans
Infection Control
Public Health
Respiratory System
Staphylococcus aureus
Universal Precautions
Urinary Tract

Reference

1. Woo JH, Lee MS, Chung MH, Lee SO, Chung DR, Kim EO, Kim YS, Kim KM, Kim MS, Kim MJ, Kim SM, Kim YS, Kim JM, Park GO, Park MD, Park ES, Bang YS, Bae HJ, Baek GR, Shin HS, Oh HS, Yoo GS, Yoo SY, Yoo JH, Yoon SW, Lee KW, Lee NY, Lee SH, Lee SH, Lee YH, Lee CG, Lee HR, Chung OH, Chung JS, Chung HJ, Jin HJ, Choi DO, Choi JS, Yoo JS, Bae JH. National survey on the current status of nosocomial infection control in Korea. Korean J Nosocomial Infect Control. 1997; 2:177–202.

2. Woo JH, Pai CH. Management of nosocomial infections. Auckland Medical Progress;1997.

3. Korean Society for Nosocomial Infection Control. Infection control and prevention in healthcare facilities. Seoul: Hanmibook;2011.

4. Edmond MB, Wenzel RP. Infection prevention in the health care setting. In : Bennet JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia: Elsevier;2015. p. 3286–3293.

5. Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, editors. Harrison's principles of internal medicine. Philadelphia: Elsevier;2016. p. 1861–1868.

6. Calfee DP. Prevention and control of health care-associated infections. In : Goldman L, Schafer AI, editors. Goldman-Cecil medicine. Philadelphia: Elsevier;2016. p. 1861–1868.

7. Haley RW, Hooton TM, Culver DH, Stanley RC, Emori TG, Hardison CD, Quade D, Shachtman RH, Schaberg DR, Shah BV, Schatz GD. Nosocomial infections in U.S. hospitals, 1975-1976: estimated frequency by selected characteristics of patients. Am J Med. 1981; 70:947–959.

8. Haley RW, Culver DH, White JW, Morgan WM, Emori TG, Munn VP, Hooton TM. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol. 1985; 121:182–205.

9. Mayon-White RT, Ducel G, Kereselidze T, Tikomirov E. An international survey of the prevalence of hospital-acquired infection. J Hosp Infect. 1988; 11:Suppl A. 43–48.

10. Choi KW. Hospital-acquired infection and infection control: trends and direction. J Korean Med Assoc. 1993; 36:1148–1152.

11. Marra AR, Edmond MB. Hand hygiene: state-of-the-art review with emphasis on new technologies and mechanisms of surveillance. Curr Infect Dis Rep. 2012; 14:585–591.

12. Lee Y, Kim YA, Song W, Lee H, Lee HS, Jang SJ, Jeong SH, Hong SG, Yong D, Lee K, Chong Y. KONSAR Group. Recent trends in antimicrobial resistance in intensive care units in Korea. Korean J Nosocomial Infect Control. 2014; 19:29–36.

13. Munoz-Price LS, Weinstein RA. Acinetobacter infection. N Engl J Med. 2008; 358:1271–1281.

14. Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A, Kallen A, Limbago B, Fridkin S. National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol. 2013; 34:1–14.

15. Roberts RR, Hota B, Ahmad I, Scott RD 2nd, Foster SD, Abbasi F, Schabowski S, Kampe LM, Ciavarella GG, Supino M, Naples J, Cordell R, Levy SB, Weinstein RA. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis. 2009; 49:1175–1184.

16. Siegel JD, Rhinehart E, Jackson M, Chiarello L. Health Care Infection Control Practices Advisory Committee. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control. 2007; 35:10 Suppl 2. S65–S164.

17. Detsky ME, Etchells E. Single-patient rooms for safe patient-centered hospitals. JAMA. 2008; 300:954–956.

18. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. CDC. Healthcare Infection Control Practices Advisory Committee. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep. 2004; 53(RR-3):1–36.

19. Ryu JS. Hospital-acquired pneumonia and blood stream infection. J Korean Med Assoc. 1993; 36:1173–1181.

20. Woo JH. Pneumonia and clinical understanding. Ulsan: University of Ulsan Press;1998.

21. Jeon MH, Kim TH, Kim SR, Chun HK, Han SH, Bang JH, Park ES, Jeong SY, Eom JS, Kim YK, Lee KY, Choi HJ, Kim HY, Kim KM, Sung J, Uh Y, Kim HB, Chung HS, Kwon JW, Woo JH. Korean Nosocomial Infections Surveillance System. Korean nosocomial infections surveillance system, intensive care unit module report: data summary from July 2012 through June 2013. Korean J Nosocomial Infect Control. 2015; 20:37–48.

22. Yokoe DS, Anderson DJ, Berenholtz SM, Calfee DP, Dubberke ER, Ellingson KD, Gerding DN, Haas JP, Kaye KS, Klompas M, Lo E, Marschall J, Mermel LA, Nicolle LE, Salgado CD, Bryant K, Classen D, Crist K, Deloney VM, Fishman NO, Foster N, Goldmann DA, Humphreys E, Jernigan JA, Padberg J, Perl TM, Podgorny K, Septimus EJ, VanAmringe M, Weaver T, Weinstein RA, Wise R, Maragakis LL. Society for Healthcare Epidemiology of America (SHEA). A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates. Infect Control Hosp Epidemiol. 2014; 35:967–977.

23. Choo EJ, Kim NJ. Prevention of nosocomial urinary tract infection. Korean J Nosocomial Infect Control. 2004; 9:1–5.

24. Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, Saint S, Schaeffer AJ, Tambayh PA, Tenke P, Nicolle LE. Infectious Diseases Society of America. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010; 50:625–663.

25. Yoo S, Jung SI, Kim GS, Lim DS, Sohn JW, Kim JY, Kim JE, Jang YS, Jung S, Pai H. Interventions to prevent catheter-associated blood-stream infections: a multicenter study in Korea. Infect Chemother. 2010; 42:216–222.

26. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009; 49:1–45.

27. Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Avery TR, Lankiewicz J, Gombosev A, Terpstra L, Hartford F, Hayden MK, Jernigan JA, Weinstein RA, Fraser VJ, Haffenreffer K, Cui E, Kaganov RE, Lolans K, Perlin JB, Platt R. CDC Prevention Epicenters Program. AHRQ DECIDE Network and Healthcare-Associated Infections Program. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med. 2013; 368:2255–2265.

28. Kim YK, Kim HY, Kim ES, Kim HB, Jin HY, Lee JY, Sung J, Uh Y, Cho YK, Lee YS, Kim EC, Woo JH. Korean surgical site infection surveillance system report: data summary from July 2010 through June 2011. Korean J Nosocomial Infect Control. 2012; 17:1–12.

29. Darouiche RO, Wall MJ Jr, Itani KM, Otterson MF, Webb AL, Carrick MM, Miller HJ, Awad SS, Crosby CT, Mosier MC, Alsharif A, Berger DH. Chlorhexidine-alcohol versus povidoneiodine for surgical-site antisepsis. N Engl J Med. 2010; 362:18–26.

30. Kim JC. Surgical site infection. J Korean Med Assoc. 1993; 36:1166–1172.

31. Park ES, Kim KS, Lee WJ, Jang SY, Choi JY, Kim JM. The economical impacts of surgical site infections. Korean J Nosocomial Infect Control. 2005; 10:57–64.

32. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 1999; 27:97–132.